| Artificial intelligence and machine learning in prostate cancer patient management—current trends and future perspectives OS Tătaru, MD Vartolomei, JJ Rassweiler, O Virgil, G Lucarelli, F Porpiglia, ... Diagnostics 11 (2), 354, 2021 | 128 | 2021 |
| Radiomics in prostate cancer: An up-to-date review M Ferro, O de Cobelli, G Musi, F Del Giudice, G Carrieri, GM Busetto, ... Therapeutic Advances in Urology 14, 17562872221109020, 2022 | 98 | 2022 |
| Prostate cancer radiogenomics—from imaging to molecular characterization M Ferro, O de Cobelli, MD Vartolomei, G Lucarelli, F Crocetto, B Barone, ... International Journal of Molecular Sciences 22 (18), 9971, 2021 | 74 | 2021 |
| Immune checkpoint inhibitors in renal cell carcinoma: molecular basis and rationale for their use in clinical practice F Lasorsa, NA di Meo, M Rutigliano, M Milella, M Ferro, SD Pandolfo, ... Biomedicines 11 (4), 1071, 2023 | 61 | 2023 |
| Radiogenomics in renal cancer management—current evidence and future prospects M Ferro, G Musi, M Marchioni, M Maggi, A Veccia, F Del Giudice, ... International journal of molecular sciences 24 (5), 4615, 2023 | 61 | 2023 |
| Cellular and molecular players in the tumor microenvironment of renal cell carcinoma F Lasorsa, M Rutigliano, M Milella, M Ferro, SD Pandolfo, F Crocetto, ... Journal of Clinical Medicine 12 (12), 3888, 2023 | 58 | 2023 |
| Metabolomic approaches for detection and identification of biomarkers and altered pathways in bladder cancer NA di Meo, D Loizzo, SD Pandolfo, R Autorino, M Ferro, C Porta, A Stella, ... International Journal of Molecular Sciences 23 (8), 4173, 2022 | 54 | 2022 |
| Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review M Ferro, F Crocetto, B Barone, F Del Giudice, M Maggi, G Lucarelli, ... Therapeutic Advances in Urology 15, 17562872231164803, 2023 | 43 | 2023 |
| Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer M Ferro, B Barone, F Crocetto, G Lucarelli, GM Busetto, F Del Giudice, ... Urologic Oncology: Seminars and Original Investigations 40 (11), 490. e13 …, 2022 | 39 | 2022 |
| Artificial intelligence in the advanced diagnosis of bladder cancer-comprehensive literature review and future advancement M Ferro, UG Falagario, B Barone, M Maggi, F Crocetto, GM Busetto, ... Diagnostics 13 (13), 2308, 2023 | 35 | 2023 |
| The impact of meat intake on bladder cancer incidence: is it really a relevant risk? A Aveta, C Cacciapuoti, B Barone, E Di Zazzo, F Del Giudice, M Maggi, ... Cancers 14 (19), 4775, 2022 | 32 | 2022 |
| Emerging hallmarks of metabolic reprogramming in prostate cancer F Lasorsa, NA di Meo, M Rutigliano, M Ferro, D Terracciano, OS Tataru, ... International Journal of Molecular Sciences 24 (2), 910, 2023 | 27 | 2023 |
| Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel … OS Tataru, M Marchioni, F Crocetto, B Barone, G Lucarelli, F Del Giudice, ... Diagnostics 13 (4), 593, 2023 | 22 | 2023 |
| Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG. R Contieri, R Hurle, M Paciotti, P Casale, A Saita, F Porpiglia, C Fiori, ... Minerva Urology and Nephrology, 2022 | 19 | 2022 |
| Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors D Balan, O Martha, CB Chibelean, S Tataru, S Voidezan, A Sin, VD Matei, ... Medicine 97 (16), e0522, 2018 | 19 | 2018 |
| Easily available blood test neutrophil-to-lymphocyte ratio predicts progression in high-risk non-muscle invasive bladder cancer O Martha, D Porav-Hodade, D Bălan, OS Tătaru, A Sin, CB Chibelean, ... Revista Romana de Medicina de Laborator 25 (2), 181-189, 2017 | 15 | 2017 |
| Efficacy of different bacillus of Calmette-Guérin (BCG) strains on recurrence rates among intermediate/high-risk non-muscle invasive bladder cancers (NMIBCs): single-arm study … F Del Giudice, V Asero, E Bologna, CM Scornajenghi, D Carino, V Dolci, ... Cancers 15 (7), 1937, 2023 | 14 | 2023 |
| Immune checkpoint inhibitors in renal cell carcinoma: Molecu‑lar basis and rationale for their use in clinical practice. Biomedicines. 2023; 11 (4): 1071 F Lasorsa, NA di Meo, M Rutigliano, M Milella, M Ferro, SD Pandolfo, ... | 10 | 2023 |
| Advanced age impacts survival after radical nephroureterectomy for upper tract urothelial carcinoma M Ferro, S Chiujdea, MD Vartolomei, P Bove, A Porreca, GM Busetto, ... Clinical Genitourinary Cancer 22 (2), 27-37, 2024 | 9 | 2024 |
| Predictors of efficacy of immune checkpoint inhibitors in patients with advanced urothelial carcinoma: a systematic review and meta-analysis M Ferro, F Crocetto, S Tataru, B Barone, P Dolce, G Lucarelli, ... Clinical Genitourinary Cancer, 2023 | 8 | 2023 |
Lucarelli GiuseppeUniversity of Bari - Department of Emergency and Organ Transplantation (DETO)- Urology Unit在 inwind.it 的电子邮件经过验证
